Best GLP-1 tracker apps: seven compared on open data (Aug 2026)

There is no single best GLP-1 tracker app — the right one depends on your platform, whether you need reminders and HealthKit or Health Connect support, and what you are willing to pay. Below are seven apps compared on open App Store and website data collected August 17, 2026 — no affiliate deals, no rankings by hype.

How this comparison works#

Seven criteria matter for a shot tracker, and they are declared up front: platforms (iOS, Android, or both), injection reminders, Apple HealthKit or Health Connect integration, a home-screen widget, a web version, price, and the store rating with its snapshot date. The last three are checkable from open data. The first four are feature claims that change with every release, so treat them as a checklist for the store page of whichever app you shortlist — not something a written review can freeze in time.

Method, stated plainly: we have not installed or tested these apps. Everything below comes from public data collected on August 17, 2026 — US App Store listings, the developers’ own websites, and their published policies. Where a number is the developer’s own claim rather than store data, we say so. The ordering is by count of US App Store ratings — a proxy for audience size, not a judgment of quality or of any medical outcome. One more note from that snapshot: none of the seven documents a browser version of the tracker itself.

Before comparing apps at all, it helps to know what a log needs: dates and doses, injection sites, one weekly weigh-in, and a short note. Any app that captures those four covers the core job.

The seven apps at a glance#

Ratings are from US App Store listings, collected August 17, 2026. “iOS” alone means an Android version was not confirmed in our data — not proof one does not exist. Prices are the highest subscription tier visible on that date.

The apps, from largest audience to smallest#

1. Shotsy — the largest dedicated tracker#

Shotsy is the biggest of the dedicated GLP-1 trackers by audience: 4.84 stars across 29,158 US App Store ratings as of August 17, 2026, the largest count of any app in this list. It is also the only one here with reported venture funding — a $2.25 million seed round, per third-party reporting — which usually buys a faster release pace than a solo project can sustain. Its website runs in nine languages and publishes its own comparison pages, so the company clearly invests in being found. The gaps in the open data: no pricing we could confirm, and no confirmed Android version. Check the current store listing for both.

2. MeAgain — cross-platform, with a dietitian on staff#

MeAgain is the closest challenger — 4.79 stars across 28,203 US ratings as of August 17, 2026 — and one of only two apps here with a confirmed Android build alongside iOS. Its App Store listing shows subscriptions up to $119.99 per year, and its website names a registered dietitian nutritionist (RDN) as nutrition lead, which is rare in this niche. The company claims 500K users; that is its own figure, and we cannot verify it. One detail worth noticing in the same snapshot: the iOS app had not shipped an update since May 20, 2026 — almost three months, unusual for an app of this size.

3. Glowise — the most detailed editorial policy#

Glowise has been in the store since November 2024 — the earliest release date we could confirm for any app here, though store dates were not available for all seven — and holds 4.78 stars across 5,465 US ratings as of August 17, 2026, on both iOS and Android. It was updated on August 11, 2026 — days before our snapshot — so it is actively maintained. It also publishes a formal medical review policy, effective July 20, 2026, that spells out reviewer credentials and correction rules: the most detailed editorial policy we found among trackers. The catch is pricing — it is not published on the website, so the actual cost only becomes visible inside the app.

4. DreamMe — a real audience with almost no website#

DreamMe is the strongest of the app-only trackers: 4.68 stars across 2,413 US ratings as of August 17, 2026, earned with essentially no web presence — its site consists of five pages. That is a genuine audience built entirely inside the store. The flip side is practical: with no meaningful website, there is no public feature list, pricing page, or editorial policy to evaluate before installing. Everything you can know in advance sits on the store listing, so read it closely before committing your log to it.

5. Vivy — small, well rated, little public information#

Vivy repeats the same pattern at smaller scale: 4.77 stars across 674 US ratings as of August 17, 2026, with a five-page website and nothing else public. The rating is high and the audience is real, just modest. As with DreamMe, the open record is thin — no published pricing, no stated policies — which does not make it a bad app, only one you have to evaluate from the store listing alone rather than from anything the developer has written down in the open.

6. GLP AI — the highest published price#

GLP AI collected 4.60 stars across 433 US ratings in roughly seven and a half months on the market, as of August 17, 2026. Its store listing shows subscriptions up to $159.99 per year — the highest published price among the apps in this list — and its small website is unusually well organized, with a page-per-medication structure and eleven browser tools. The trade-off is plain: the smallest audience of the paid apps here and the lowest average rating in this list, although 4.60 stars is still a strong score in absolute terms.

7. Shotlee — free, with numbers to double-check#

Shotlee launched on January 15, 2026 and takes the opposite pricing stance: its website says the app is completely free, with no hidden fees. Two caveats belong next to that. First, its US App Store listing showed 7 ratings (5.0 average) as of August 17, 2026, while its homepage advertises “25k+ Active Users” and “4.8 from 1,523 reviews” — figures that may include other storefronts but do not match the US data we can see. Second, the App Store lists an individual developer rather than a company, and the site leans heavily toward research peptides, not just GLP-1 medications. If free is the deciding factor, look — with expectations calibrated.

If you track a specific medication#

All seven apps track any weekly injectable — the brand mostly changes labels inside the app, not the mechanics. If you searched by brand rather than by category, we keep separate notes on what to look for in an Ozempic tracker app, a Wegovy tracker app, a Mounjaro tracker app, and a Zepbound tracker app. And if you think in ingredient terms instead, the same comparison logic applies to a semaglutide tracker or a tirzepatide tracker — every app above handles both molecules the same way.

When a tracker app is overkill#

An app is a commitment: an install, sometimes an account, often a subscription. Plenty of GLP-1 situations do not need one. If your dose is stable, your shot lands on the same weekday, and your appointments are regular, a calendar reminder and a notes app already cover the record a prescriber asks for. One-off calculations are even clearer: converting milligrams to syringe units, laying out titration dates, or counting the days a pen has spent out of the fridge are single calculations, not daily logs — free browser tools handle them without an install or an account. The honest test: if you would open the app less than once a week, you do not need the app. Start with paper or a browser, and upgrade when the record outgrows them.

The verdict, by situation#

There is no overall winner — there are conditions. If you want the largest track record on iOS, Shotsy’s 29,158 US ratings at 4.84 stars (August 17, 2026) are the biggest sample of user opinion in the niche, though you will have to check its pricing yourself. If you are on Android, the confirmed options in our data are MeAgain and Glowise: MeAgain has the far larger audience, while Glowise showed the fresher release cadence and publishes a medical review policy — and those same two are the only apps here that show editorial credentials in the open. If you will not pay, Shotlee claims free forever — go in knowing its US review base was seven ratings at the snapshot. If you want a small, focused app and are comfortable judging it from the store page, DreamMe and Vivy both hold high ratings without any web presence to speak of.

Whichever way you lean, verify the four volatile criteria — reminders, widget, HealthKit or Health Connect — on the current store listing before installing. Those change faster than any review can.

Full disclosure: we are building one#

We make KeepAlong, a GLP-1 shot tracker app with injection-day reminders, a home-screen widget, and Apple Health integration. It is not released in the stores yet, which is exactly why it is not in the list above — a rating you cannot check is not a rating. When it ships, we will add it here and score it by the same criteria as everyone else. Who we are is on the record, including the part where nobody on the team holds a medical license.

KeepAlong is an independent app and website. Not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.